Monday, June 22, 2026

AI-Powered Healthcare: A Game Changer for Diagnosis?

Korean tech companies are developing AI-powered tools for the medical field. These tools aim to analyze patient data and...

Coupang Data Breach: How an ISDS Claim Could Spark an International Dispute

Coupang faces international arbitration over a data breach, with U.S. shareholders claiming unfair treatment by South Korea's government.

Ending a Friendship Over Herpes: A Misunderstanding of Type 1 vs. Type 2

A woman ended a friendship after being accused of having an STI due to a cold sore, despite explaining it was a stress-induced outbreak.

Tag: SJN314

SJN314: The Promising New Immunotherapy for Chronic Inflammatory Diseases in Asia

Samjin Pharmaceutical submits phase 1 trial plan for SJN314, targeting immune diseases, aiming for global partnerships in early clinical phases.

Top News

- Our Sponsors Ad -

Follow us